Surrogate markers of NAFLD, including γ-glutamyltransferase (GGT) [42] and ALT [44] or fatty liver indices [43], have been shown to be predictive of diabetes [42]–[44] in prospective studies. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.